A partially-purified neuraminidase from the mucinase complex of Vibrio cholerae was used to prepare a specific anti-neuraminidase antiserum in rabbits. When the neutralising potency of this serum against V . cholerae neuraminidase was assessed in conventional tests, the enzymic activity, as measured by thiobarbituric acid, methoxyphenol-neuraminate and goblet-cell assays, apparently increased. These results are attributable to the presence of a sialylated glycoprotein substrate and small amounts of sialidase in the crude antiserum. However, a twice-purified DEAE-IgG fraction of the antiserum neutralised the enzymic activity of the V. cholerae neuraminidase.
Introduction
The mucinase complex of Vibrio cholerae contains neuraminidase, endo-P-N-acetylhexosaminidase, nicotinamide-adenine-dinucleotidase and proteinases (Stewart-Tull et al., 1986) . These enzymes interact in the breakdown of intestinal mucus and aid the adhesion of V. cholerae organisms to the epithelial surface (Schrank and Verwey, 1976; Freter et al., 1978 Freter et al., , 1981 Reed and Williams, 1978) . The work of Palese et al. (1973) with viral neuraminidase seemed to indicate that it was not neutralised by a specific antiserum because the antibody molecules failed to block the active site of the enzyme. During our search for an acellular cholera vaccine it seemed worthwhile to re-examine the neutralisation of the enzymes of the mucinase complex as a means of preventing colonisation of the intestinal surface. 
Materials and methods

Bacterium
Goblet cell assay
This method was as described by Ollar and StewartTull (1987) . The data were analysed statistically by Student's t test (two tailed); the goblet cell counts in the untreated control were compared with those in sections treated with neuraminidase preparations alone or in combination with rabbit normal or immune serum.
Production of V. cholerae anti-neuraminidase
Anti-neuraminidase antiserum DST/R77 was prepared by immunising rabbits with 1 ml of a mixture containing Sephadex G 1 OO/N semi-purified V. cholerae neuraminidase 0.5 ml, saline 1 ml, Bayol F 1.5 ml, and Arlacel A 0.6 ml. The animals were given an injection of the mixture (0-5 ml) intramuscularly into each hind leg. The mixture for injection into rabbit DST/R78 was similar, but commercial V . cholerae neuraminidase (Koch-Light), 100 ImU/O-5 ml, was used. A booster injection of the appropriate preparation (2 ml) was given intraperitoneally to each rabbit after one month. Ten days later, a blood sample was taken from an ear vein and the serum was tested for the presence of anti-neuraminidase antibodies against the commercial V. cholerae neuraminidase by the double diffusion gel test of Ouchterlony (1949) . If a positive reaction was observed, animals were killed and exsanguinated by cardiac puncture or by bleeding from the posterior vena cava; the serum was collected and stored at -20°C. D. E. S. STEWART-TULL AND R. A. OLLAR 0.01 M phosphate buffer, pH 7-5. A glass column (1.5 x 25 cm) was filled with DE 52 slurry and equilibrated with several column volumes of the same buffer. Rabbit antineuraminidase serum (DST/R77 or DST/R78,4 ml) was placed in dialysis (Visking) tubing, dialysed overnight at 4°C against 0.01 M phosphate buffer,pH 7.5, and applied to the column. The flow-rate of the column was 0.8 ml/ min and fractions (2 ml) were collected. The first protein peak eluted with the 0.01 M phosphate buffer contained IgG. The fractions containing IgG were pooled and concentrated with Carbowax to 4 ml. This purified IgG fraction was re-chromatographed on DE 52 by a similar procedure.
The IgG was also separated from normal rabbit serum by this method and was used as the negative control preparation.
Neutralisation of V . cholerae neuraminidase with rabbit normal or anti-neuraminidase whole sera and their IgG fractions Rabbit anti-neuraminidase serum (DST/R77 or DST/ R78) or normal serum or the twice-purified IgG fraction from each of these sera (0.05-0-5m1, as detailed) was mixed with 0.2 ml of one of the V. cholerae neuraminidase fractions (G100/N2-G 100/N4) described by Stewart-Tull et al. (1986) , or with Clostridium perfringens neuraminidase. The neuraminidase activity of each of the enzyme preparations added (0-2 ml) was: G100/N2 11.0 ImU; G 1 OO/N3 3-99 ImU ; G 100/N4 5.12 ImU ; and C. perfringens 60-0 ImU. The final volume of the neutralisation mixture was adjusted to 0-7 ml by the addition of 0-05 M sodium acetate buffer (NaAc)pH 5.5. Enzyme plus buffer alone and serum samples plus buffer alone were included as controls. Each mixture was incubated for 2 h at 37°C and left overnight at 4°C. The mixtures were centrifuged at 1200 g for 5 min and the supernates were retained for the studies detailed below.
Studies of the eflect of speci$c anti-neuraminidase antibodies on V. cholerae neuraminidase measured by the TBA and MPN assays Neuraminidase samples from V. cholerae (final concentration in assays: G100/N2, 1-57 ImU; G100/N3, 0.57 ImU; G100/N4, 0.73 ImU) and C. perfringens (Sigma; 4.3 ImU) treated with whole serum or the IgG of rabbit anti-neuraminidase serum by the procedure described above, were subsequently tested for neuraminidase activity by the thiobarbituric acid (TBA) and methoxyphenol-neuraminate (MPN) assays described by Stewart-Tull et al. (1986) . In the TBA assay, controls included neuraminidase plus either DST/R78 antineuraminidase whole serum or its IgG fraction, or normal rabbit serum but without the addition of bovine submaxillary mucin, in order to check for the possible addition of sialic acid from the serum. In addition, (i) neuraminidase plus 0.05 M NaAc, PH 5.5, (ii) DST/R77 or DSTI NaAc, and (iv) normal serum plus NaAc were included as controls in both assays. Samples (0.2 ml) of the treated neuraminidase preparations (final concentration V . cholerae G 100/N2, 3.4 ImU; G100/N3, 1-14 ImU; G100/N4, 1.46 ImU and C. perfringens 8.6 ImU) were pipetted on to rat ileal tissue sections, 8 pm thick on glass microscope slides, cut in a cryostat, as described by Ollar and Stewart-Tull (1987) . The sections covered with a neuraminidase sample were incubated in a moist chamber at 37°C for 24 h. Subsequently, the sections were stained by the Alcian blue/ PAS procedure (Mowry and Winkler, 1956 ) and histochemical changes in the mucin were measured by the goblet-cell assay (Ollar and Stewart-Tull, 1987) .
Results
Neutralisation of neuraminidase activity by rabbit anti-neuraminidase sera DSTIR77 and DST/R78
The neutralisation of partially-purified V. cholerae neuraminidase preparations (G 100/N2, 1.57 ImU; G100/N3, 0.57 ImU; G100/N4, 0.73 ImU) with rabbit anti-V. cholerae neuraminidase serum DST/R77 (0.05-0.3 ml) caused a reduction in the amount of N-acetyl neuraminic acid (NANA) released from bovine submaxillary mucin by the enzyme, as measured by the TBA assay. Maximum enzyme neutralisation was obtained with 0.3 ml of the V. cholerae antiserum. However, when further amounts of this serum (0.35-0-5 ml) were added to these neuraminidase preparations, the effect appeared to be reversed (table) .
In addition, the neuraminidase preparations released a TBA-reactive substance, possibly NANA, from the serum DST/R77 (0.5 ml) in a control mixture without bovine submaxillary mucin (GlOO/Nz 1.25 pg, GlOO/N3 0.5 pg, G100/N4 1.85 pg). The same serum DST/R77 appeared to add a small amount (0.5 pg) of TBA-reactive substance as revealed by the control test to which neuraminidase was not added.
To check whether the neuraminidases released NANA from the antiserum DST/R77, these experiments were repeated with the substrate-specific MPN assay. As the amount of antiserum was increased from 0.3 ml to 0.5 ml, surprisingly, there was a corresponding increase in the amount of methoxyphenol liberated (78 to 118 nmoles).
After these initial experiments it was decided to purify the IgG fraction of normal and antineuraminidase rabbit serum. In the TBA assay the specific rabbit anti-V. cholerae neuraminidase serum DST/R78 (0.05-0.2 ml) reduced the activity of the G 100/N2 neuraminidase when compared with the untreated enzyme preparation ( fig. la) . Normal rabbit serum did not neutralise neuraminidase activity but, on the contrary, accentuated it ( fig. 1 b) . However, with the twice-purified specific anti-V. cholerae neuraminidase IgG, 0.05-0.2 ml, complete neutralisation of the neuraminidase occurred; normal serum IgG neither neutralised nor enhanced the neuraminidase activity ( fig. 1). b IgG preparation or serum added (ml) Results with the more sensitive MPN assay indicated that the specific rabbit anti-V. cholerae neuraminidase serum DST/R78 did not neutralise enzymic activity but accentuated it in a manner similar to that found with normal serum ( figs. 2a,b) . The twice-purified IgG fraction of this antiserum DST/R78 significantly reduced the level of neuraminidase activity, whereas the twice purified IgG fraction of normal serum did not ( figs. 2a,b) .
The eflect of speciJic immunoglobulins on the neutralisation of V. cholerae neuraminidase activity in ileal tissue sections
An examination of rat ileal tissue sections in the goblet-cell assay showed a significant difference (p<O.O2; with 38 degrees of freedom in all tests) between the number of goblet cells stained with Alcian blue in untreated sections or those treated with the V. cholerae G100/N2 neuraminidase preparation (1.57 ImU in assay) alone (477/cm2 field area) or in combination with 0-1 ml of normal rabbit serum (353/cm2). However, as the amount of normal rabbit serum was increased, to a maximum of 0.4 ml, there was a significant decrease in alcianophilia in the goblet cells (p < 0-0002) and concomitantly a significant increase in the number of magenta-stained, PAS-positive goblet cells (p < 0.0002). For example, when the G 1 QO/N2 preparation, in combination with normal rabbit serum, 0.4 ml, was used to treat a rat ileal section, the alcianophilia decreased from 477/cm2 field area in the untreated section to 230/cm2 (p<0.0002). Similarly, the numbers of magenta PAS-stained cells were 98/cm2 in the untreated and 244/cm2 in the treated section (p < 0.0002).
Subsequent experiments were done with the rabbit anti-neuraminidase whole serum DST/R78 and its twice-purified IgG. Fig. 3 shows that a similar decrease was observed in the number of alcianophilic goblet cells after treatment of rat ileal sections with the G100/N2 V. cholerae neuraminidase (262/cm2; p<O.OOl) and an even greater decrease after treatment with G 100/N2 neuraminidase plus anti-neuraminidase serum (1 83/cm2 ; p<0.0002). In addition, there was a significant decrease in the number of alcianophilic goblet cells in control sections treated with a similar amount of anti-neuraminidase serum alone (21 8/cm2 ; p < 0.001). In all instances there was an associated increase in the number of magenta-stained goblet cells (308/cm2, p < 0.0002; 529/cm2, p < 0.0002; 485/cm2, p < 0.0002 respectively).
In contrast, when the DEAE twice-purified antineuraminidase IgG preparation was used in a purified cholera neuraminidase preparations are able to release small quantities of TBA-reactive substances from rabbit serum glycoprotein. However, it seems that the removal of neuraminic acid residues from serum glycoproteins is unlikely to be a major factor in the pathogenesis of cholera as, in general, the plasma protein concentration in cholera is greatly increased by the loss of fluid and
Discussion
As part of a broad study to isolate and characterise possible protective antigens of V. cholerae suitable for use in an acellular vaccine it was important to know whether the neuraminidase was functionally and antigenically distinct from mammalian neuraminidase and also whether it was immunogenic in the mammalian host.
In higher vertebrates, neuraminidases (sialidases) are associated with lysosomes and other cell organelles. Mammalian neuraminidases may remove sialic acid residues and thus regulate the amount of glycoprotein circulating in serum (Hutchinson and Kabayo, 1977) . The sialic acid residue protects the serum glycoprotein from catabolism but neuraminidase exposes a terminal galactose residue which can bind to a galactosespecific lectin on hepatocytes, the first step in the degradation process (Ashwell and Morell, 1974) . The result of our study indicates that partially electrolytes. Ramphal and Pyle (1983) noted that the activity of neuraminidases on neuraminic acid-containing glycoproteins depended upon the source of the enzyme. This was examined previously by Finne (1978) with the neuraminidases from V. cholerae and C . perfringens. The V. cholerae enzyme cleaved neuraminic acid from follicle stimulating hormone (FSH) but did not act on luteinising hormone (LH). In contrast, C. perfringens enzyme acted on FSH and LH. Whether this substrate specificity might be due to the presence of different antigenic determinants in the enzymes from these two bacteria was a point for consideration.
In our study, both the V . cholerae partiallypurified neuraminidase and rabbit serum neuraminidase released free methoxyphenol in the substratespecific MPN assay. It would follow from Finn6 (1978) that these neuraminidases share common antigenic determinants. Consequently, there was an initial doubt about the ability of the V. cholerae Note that the cells are over-distributed in many instances (SD > &)which reflects the distribution of goblet cells within random fields (see Wardlaw, 1985) .
neuraminidase to elicit an immune response in the rabbit. The results presented here reveal that substrate specificity is not correlated with antigenic specificity as it was possible to raise anti-V. cholerae neuraminidase antibodies in rabbits. Palese et al. (1973) produced evidence that although viral neuraminidases stimulated the production of antibodies in rabbits, these antisera did not neutralise enzyme action as measured by the MPN assay. In our initial experiments, rabbit V. cholerae anti-neuraminidase DST/R77 serum neutralised V. cholerae activity by 58% and C. perfringens activity by 70%, which also indicated a considerable antigenic similarity between the neuraminidases from these two organisms. However, as the amount of whole serum, used to neutralise the enzyme, was increased, there appeared to be an associated increase in enzyme activity. This might be associated with a sialylated serum glycoprotein or a serum neuraminidase, or both, as discussed above. The greater increase in the amount of NANA released in the less substrate-specific TBA than methoxyphenol in the specific MPN assay suggests that the apparent increase in activity was due to the addition of extra substrate from the serum. Nevertheless, the results from the gobletcell assay clearly indicate the presence of a serum neuraminidase in the rabbit anti-neuraminidase DST/R78 serum since there was a great reduction in the observed alcianophilia in the goblet cells of ileal sections treated with this serum. The values obtained in the TBA and MPN assays with whole serum, therefore, represent the net result of enzyme neutralisation and additional enzyme activity.
These findings explain the lack of neutralisation observed by Palese et al. (1973) . After purification twice by DEAE chromatography, the IgG fraction of the rabbit anti-neuraminidase serum neutralised the activity of the enzyme, but lacked any neuraminidase activity itself. It could also be argued from the results that the rabbit anti-V. cholerae neuraminidase could contain antibodies against an enzyme inhibitor present in the partially-purified V. cholerae neuraminidase preparations used to binding of the antibody to the V. cholerae neuraminidase might induce the activation of .a proenzyme and cause an increase in activity. The experiments with the twice-purified IgG of rabbit anti-neuraminidase serum would disprove both possibilities because the neuraminidase was neutralised. The neuraminidase complex plays an important role in the breakdown of the intestinal sialomucin enabling the organism to colonise the epithelial surface and to release its enterotoxin (Stewart-Tull et al., 1986) . raise the antiserum. If such a n inhibitor was precipitated with antibody, the specific neuraminidase activity would increase. Furthermore, the It remains to be shown whether anti-V. cholerae neuraminidase antibodies can protect against an infection with V. cholerae.
